BIOCRYST PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,953 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
S-8 File 333-211529

S-8

Filing date
23 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-202466

EFFECT filing

Filing date
18 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44055

SEC SCHEDULE 13G

Filing date
11 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-23186

DEFINITIVE ADDITIONAL MATERIALS

Filing date
11 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-23186

DEFINITIVE PROXY STATEMENT

Filing date
11 Apr 2016
Reporting date
23 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-44055

SCHEDULE 13G 3-28-16

Filing date
28 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-44055

SCHEDULE 13G

Filing date
14 Mar 2016
Reporting date
Not listed
Next action
Verify source filing
SC 13G/A File 005-44055

SC 13G/A filing

Filing date
10 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
08 Mar 2016
Reporting date
02 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
07 Mar 2016
Reporting date
07 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-202466

POS AM

Filing date
26 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
23 Feb 2016
Reporting date
23 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .